Healthcare >> CEO Interviews >> October 3, 2014
Scott Pancoast is President and CEO of Lpath, Inc. From 1994 to 2004, Mr. Pancoast was managing partner of Western States Investment Corporation — WSIC — a private San Diego venture capital fund with $30 million to $100 million under management depending on the time period. During that time, he was CEO or Interim CEO for six startup companies and served on the board of directors for over 15 companies, including three public ones. Prior to joining WSIC, he started and ran the Midwest division of a $300 million — in revenues — publicly traded company. He served as the Chairman/President of the San Diego Venture Group during the late-1990s. Mr. Pancoast earned a bachelor’s degree from the University of Virginia and an MBA from the Harvard Business School. Profile
Mr. Pancoast: Lpath is the category leader in the discovery and development of monoclonal antibodies
